Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

Recruiting now · Not applicable

Conditions studied: Pulmonary Arterial Hypertension, Pulmonary Hypertension, Right Heart Dysfunction

In brief

This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.

Key facts

Study ID

NCT04555161

Run by

Aria CV, Inc

People needed

30

Starts

2021-03-15

Expected to finish

2026-10-01

Last updated by the study team

2025-09-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Ohio Health — Columbus, Ohio, United States (enrolling)
• Medical University of South Carolina — Charleston, South Carolina, United States (enrolling)
• St. Vincent Health — Indianapolis, Indiana, United States (enrolling)
• Brigham and Women's Hospital — Boston, Massachusetts, United States (enrolling)
• University of Minnesota — Minneapolis, Minnesota, United States (enrolling)
• Mayo Clinic — Rochester, Minnesota, United States (enrolling)
• Cornell University — New York, New York, United States (enrolling)
• University of Rochester — New York, New York, United States (enrolling)
• University of California-Los Angeles — Los Angeles, California, United States (enrolling)
• Aurora St Luke's Medical Center — Milwaukee, Wisconsin, United States
• The Christ Hospital — Cincinnati, Ohio, United States
• University of California - San Diego — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.